⌘K

Login Start Free

Home/Filings/4/0000950170-25-071961

4//SEC Filing

Barry Richard 4

Accession 0000950170-25-071961

CIK 0000873303other

View on SEC.gov Company Profile

Filed

May 14, 8:00 PM ET

Accepted

May 15, 7:00 AM ET

Size

11.4 KB

Accession

0000950170-25-071961

Insider Transaction Report

Form 4

Period: 2025-05-13

Sarepta Therapeutics, Inc.SRPT

Director

Transactions

Exercise/Conversion
Common Stock
2025-05-13$25.18/sh+9,746$245,404→ 2,943,817 total
Exercise/Conversion
Stock Option (right to buy)
2025-05-13−10,500→ 0 total
Exercise: $13.71From: 2017-02-28Exp: 2026-02-28→ Common Stock (10,500 underlying)
Exercise/Conversion
Common Stock
2025-05-13$13.71/sh+10,500$143,955→ 2,954,317 total
Exercise/Conversion
Stock Option (right to buy)
2025-05-13−9,746→ 0 total
Exercise: $25.18From: 2016-06-02Exp: 2025-06-02→ Common Stock (9,746 underlying)

Holdings

Common Stock
(indirect: By Trust)
240,000
Common Stock
(indirect: By LLC)
10,000

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1

filerCIK 0001562371

Filing Metadata

Form type: 4
Filed: May 14, 8:00 PM ET
Accepted: May 15, 7:00 AM ET
Size: 11.4 KB

View on SEC.gov